Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study.
The interaction of anthracyclines (daunorubicin and idarubicin) with monolayers of zwitterionic palmitoyloleoylphosphatidylcholine (POPC) and anionic dipalmitoylphosphatidic acid (POPC-DPPA 80-20 mol%) was studied by surface pressure measurements and compared with previous results obtained with other anthracyclines (pirarubicin and adriamycin). These anthracycline/phospholipid monolayers were next transferred by a Langmuir-Blodgett technique onto planar supports and studied by surface-enhanced resonance Raman scattering (SERRS), which gave information about the orientation of anthracycline in the monolayers. On the whole, the adsorption of anthracyclines in zwitterionic monolayers increases with the anthracycline hydrophobic/hydrophilic balance, which underlines the role of the hydrophobic component of the interaction. On the contrary, the anthracyclines remain adsorbed on the polar headgroups of the phospholipids in the presence of DPPA and form a screen that limits a deeper penetration of other anthracycline molecules. To study by SERRS measurements the crossing of pirarubicin through a phospholipid bilayer used as a membrane model, asymmetrical POPC-DPPA/POPC or POPC/POPC-DPPA bilayers were transferred by the Langmuir-Schäfer method, thanks to a laboratory-built set-up, and put in contact with a pirarubicin aqueous solution. It has been shown that the presence of anionic DPPA in the first monolayer in contact with pirarubicin would limit its crossing. This limiting effet is not observed if the first monolayer is zwitterionic.
Heywang
C
C
Laboratoire de Physicochimie Biomoléculaire et Cellulaire, URA CNRS 2056, Université Pierre et Marie Curie, 75252 Paris cedex 05, France.
Saint-Pierre Chazalet
M
M
Masson
C M
CM
Bolard
J
J
D000903:Antibiotics, Antineoplastic / Q000737:chemistry*; D003630:Daunorubicin / Q000737:chemistry; D004317:Doxorubicin / Q000031:analogs & derivatives / Q000737:chemistry; D015255:Idarubicin / Q000737:chemistry; D008051:Lipid Bilayers / Q000737:chemistry; D015394:Molecular Structure; D010712:Phosphatidic Acids / Q000737:chemistry; D010713:Phosphatidylcholines / Q000737:chemistry; D010743:Phospholipids / Q000737:chemistry*; D011312:Pressure; D012542:Scattering, Radiation; D013059:Spectrum Analysis, Raman; D013499:Surface Properties
D000903:Antibiotics, Antineoplastic; D008051:Lipid Bilayers; D010712:Phosphatidic Acids; D010713:Phosphatidylcholines; D010743:Phospholipids; C031599:dipalmitoylphosphatidic acid; D004317:Doxorubicin; C027260:pirarubicin; C028694:1-palmitoyl-2-oleoylphosphatidylcholine; D015255:Idarubicin; D003630:Daunorubicin